FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3001650767> ?p ?o ?g. }

• W3001650767 endingPage "8" @default.
• W3001650767 startingPage "8" @default.
• W3001650767 abstract "Beginning in June of 2019, there was a marked increase in reported cases of serious pulmonary injury associated with vaping. The condition, referred to as e-cigarette or vaping product use-associated lung injury (EVALI), does not appear to involve an infectious agent; rather, a chemical adulterant or contaminant in vaping fluids is suspected. In August of 2019, the Wadsworth Center began receiving vaporizer cartridges recovered from patients with EVALI for analysis. Having no a priori information of what might be in the cartridges, we employed untargeted analyses using gas chromatography-mass spectrometry and high-resolution mass spectrometry to identify components of concern. Additionally, we employed targeted analyses used for New York medical marijuana products. Here, we report on the analyses of 38 samples from the first 10 New York cases of EVALI for which we obtained cartridges. The illicit fluids had relatively low cannabinoid content, sometimes with unusual Δ9-/Δ8-tetrahydrocannabinol ratios, sometimes containing pesticides and many containing diluents. A notable diluent was α-tocopheryl acetate (vitamin E acetate; VEA), which was found in 64% of the cannabinoid-containing fluids. To investigate potential sources of the VEA, we analyzed six commercial cannabis-oil diluents/thickeners. Three were found to be >95% VEA, two were found to be primarily squalane, and one was primarily α-bisabolol. The cause(s) of EVALI is unknown. VEA and squalane are components of some personal care products; however, there is growing concern that vaping large amounts of these compounds is not safe." @default.
• W3001650767 created "2020-01-30" @default.
• W3001650767 creator A5015426098 @default.
• W3001650767 creator A5017587376 @default.
• W3001650767 creator A5018176610 @default.
• W3001650767 creator A5018687466 @default.
• W3001650767 creator A5027009626 @default.
• W3001650767 creator A5029009331 @default.
• W3001650767 creator A5049368562 @default.
• W3001650767 creator A5058669502 @default.
• W3001650767 creator A5061395845 @default.
• W3001650767 creator A5074355077 @default.
• W3001650767 date "2020-01-24" @default.
• W3001650767 modified "2023-09-27" @default.
• W3001650767 title "Analysis of Cannabinoid-Containing Fluids in Illicit Vaping Cartridges Recovered from Pulmonary Injury Patients: Identification of Vitamin E Acetate as a Major Diluent" @default.
• W3001650767 cites W1966099948 @default.
• W3001650767 cites W2053247706 @default.
• W3001650767 cites W2126721276 @default.
• W3001650767 cites W2167795167 @default.
• W3001650767 cites W2333728271 @default.
• W3001650767 cites W2470236573 @default.
• W3001650767 cites W2519195313 @default.
• W3001650767 cites W2521764737 @default.
• W3001650767 cites W2551639540 @default.
• W3001650767 cites W2564967498 @default.
• W3001650767 cites W2565810366 @default.
• W3001650767 cites W2801133958 @default.
• W3001650767 cites W2809772561 @default.
• W3001650767 cites W2853044160 @default.
• W3001650767 cites W2886108045 @default.
• W3001650767 cites W2902248795 @default.
• W3001650767 cites W2910476157 @default.
• W3001650767 cites W2913428530 @default.
• W3001650767 cites W2915016446 @default.
• W3001650767 cites W2920685155 @default.
• W3001650767 cites W2922085047 @default.
• W3001650767 cites W2922215682 @default.
• W3001650767 cites W2925107216 @default.
• W3001650767 cites W2936266369 @default.
• W3001650767 cites W2942062322 @default.
• W3001650767 cites W2951376025 @default.
• W3001650767 cites W2971846128 @default.
• W3001650767 cites W2971850682 @default.
• W3001650767 cites W2972010736 @default.
• W3001650767 cites W2978514385 @default.
• W3001650767 cites W2979124778 @default.
• W3001650767 cites W2979811506 @default.
• W3001650767 cites W2980132296 @default.
• W3001650767 cites W2981082347 @default.
• W3001650767 cites W2981636359 @default.
• W3001650767 cites W2985955404 @default.
• W3001650767 cites W2991638606 @default.
• W3001650767 cites W35620663 @default.
• W3001650767 doi "https://doi.org/10.3390/toxics8010008" @default.
• W3001650767 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7151740" @default.
• W3001650767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31991538" @default.
• W3001650767 hasPublicationYear "2020" @default.
• W3001650767 type Work @default.
• W3001650767 sameAs 3001650767 @default.
• W3001650767 citedByCount "68" @default.
• W3001650767 countsByYear W30016507672020 @default.
• W3001650767 countsByYear W30016507672021 @default.
• W3001650767 countsByYear W30016507672022 @default.
• W3001650767 countsByYear W30016507672023 @default.
• W3001650767 crossrefType "journal-article" @default.
• W3001650767 hasAuthorship W3001650767A5015426098 @default.
• W3001650767 hasAuthorship W3001650767A5017587376 @default.
• W3001650767 hasAuthorship W3001650767A5018176610 @default.
• W3001650767 hasAuthorship W3001650767A5018687466 @default.
• W3001650767 hasAuthorship W3001650767A5027009626 @default.
• W3001650767 hasAuthorship W3001650767A5029009331 @default.
• W3001650767 hasAuthorship W3001650767A5049368562 @default.
• W3001650767 hasAuthorship W3001650767A5058669502 @default.
• W3001650767 hasAuthorship W3001650767A5061395845 @default.
• W3001650767 hasAuthorship W3001650767A5074355077 @default.
• W3001650767 hasBestOaLocation W30016507671 @default.
• W3001650767 hasConcept C127413603 @default.
• W3001650767 hasConcept C170493617 @default.
• W3001650767 hasConcept C175804951 @default.
• W3001650767 hasConcept C178790620 @default.
• W3001650767 hasConcept C185592680 @default.
• W3001650767 hasConcept C2780871563 @default.
• W3001650767 hasConcept C2908858883 @default.
• W3001650767 hasConcept C33070731 @default.
• W3001650767 hasConcept C34381374 @default.
• W3001650767 hasConcept C43617362 @default.
• W3001650767 hasConcept C55493867 @default.
• W3001650767 hasConcept C78519656 @default.
• W3001650767 hasConcept C86803240 @default.
• W3001650767 hasConceptScore W3001650767C127413603 @default.
• W3001650767 hasConceptScore W3001650767C170493617 @default.
• W3001650767 hasConceptScore W3001650767C175804951 @default.
• W3001650767 hasConceptScore W3001650767C178790620 @default.
• W3001650767 hasConceptScore W3001650767C185592680 @default.
• W3001650767 hasConceptScore W3001650767C2780871563 @default.
• W3001650767 hasConceptScore W3001650767C2908858883 @default.
• W3001650767 hasConceptScore W3001650767C33070731 @default.
• W3001650767 hasConceptScore W3001650767C34381374 @default.

• next